283 related articles for article (PubMed ID: 15304086)
21. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
[TBL] [Abstract][Full Text] [Related]
22. Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations.
Lacroix M; Lacaze-Buzy L; Furio L; Tron E; Valari M; Van der Wier G; Bodemer C; Bygum A; Bursztejn AC; Gaitanis G; Paradisi M; Stratigos A; Weibel L; Deraison C; Hovnanian A
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):575-82. PubMed ID: 22089833
[TBL] [Abstract][Full Text] [Related]
23. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.
Chavanas S; Bodemer C; Rochat A; Hamel-Teillac D; Ali M; Irvine AD; Bonafé JL; Wilkinson J; Taïeb A; Barrandon Y; Harper JI; de Prost Y; Hovnanian A
Nat Genet; 2000 Jun; 25(2):141-2. PubMed ID: 10835624
[TBL] [Abstract][Full Text] [Related]
24. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
[TBL] [Abstract][Full Text] [Related]
25. Netherton syndrome in one Chinese adult with a novel mutation in the SPINK5 gene and immunohistochemical studies of LEKTI.
Xi-Bao Z; San-Quan Z; Yu-Qing H; Yu-Wu L; Quan L; Chang-Xing L
Indian J Dermatol; 2012 Jul; 57(4):265-8. PubMed ID: 22837558
[TBL] [Abstract][Full Text] [Related]
26. Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum.
Ng E; Hale CS; Meehan SA; Cohen DE
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526335
[TBL] [Abstract][Full Text] [Related]
27. Deleterious mutations in SPINK5 in a patient with congenital ichthyosiform erythroderma: molecular testing as a helpful diagnostic tool for Netherton syndrome.
Sprecher E; Tesfaye-Kedjela A; Ratajczak P; Bergman R; Richard G
Clin Exp Dermatol; 2004 Sep; 29(5):513-7. PubMed ID: 15347338
[TBL] [Abstract][Full Text] [Related]
28. LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.
Mägert HJ; Kreutzmann P; Ständker L; Walden M; Drögemüller K; Forssmann WG
Int J Biochem Cell Biol; 2002 Jun; 34(6):573-6. PubMed ID: 11943586
[TBL] [Abstract][Full Text] [Related]
29. A case of a Japanese neonate with congenital ichthyosiform erythroderma diagnosed as Netherton syndrome.
Mizuno Y; Suga Y; Haruna K; Muramatsu S; Hasegawa T; Kohroh K; Shimizu T; Komatsu N; Ogawa H; Ikeda S
Clin Exp Dermatol; 2006 Sep; 31(5):677-80. PubMed ID: 16901309
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: in vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1.
Oji V; Oji ME; Adamini N; Walker T; Aufenvenne K; Raghunath M; Traupe H
Br J Dermatol; 2006 May; 154(5):860-7. PubMed ID: 16634887
[TBL] [Abstract][Full Text] [Related]
31. Comèl-Netherton syndrome defined as primary immunodeficiency.
Renner ED; Hartl D; Rylaarsdam S; Young ML; Monaco-Shawver L; Kleiner G; Markert ML; Stiehm ER; Belohradsky BH; Upton MP; Torgerson TR; Orange JS; Ochs HD
J Allergy Clin Immunol; 2009 Sep; 124(3):536-43. PubMed ID: 19683336
[TBL] [Abstract][Full Text] [Related]
32. Ichthyosis Linearis Circumflexa as the Only Clinical Manifestation of Netherton Syndrome.
Guerra L; Fortugno P; Pedicelli C; Mazzanti C; Proto V; Zambruno G; Castiglia D
Acta Derm Venereol; 2015 Jul; 95(6):720-4. PubMed ID: 25710899
[TBL] [Abstract][Full Text] [Related]
33. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.
Descargues P; Deraison C; Bonnart C; Kreft M; Kishibe M; Ishida-Yamamoto A; Elias P; Barrandon Y; Zambruno G; Sonnenberg A; Hovnanian A
Nat Genet; 2005 Jan; 37(1):56-65. PubMed ID: 15619623
[TBL] [Abstract][Full Text] [Related]
34. LEKTI-1 in sickness and in health.
Roelandt T; Thys B; Heughebaert C; De Vroede A; De Paepe K; Roseeuw D; Rombaut B; Hachem JP
Int J Cosmet Sci; 2009 Aug; 31(4):247-54. PubMed ID: 19467033
[TBL] [Abstract][Full Text] [Related]
35. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
Wiegmann H; Valentin F; Tarinski T; Liebau E; Loser K; Traupe H; Oji V
Br J Dermatol; 2019 Nov; 181(5):999-1008. PubMed ID: 30801672
[TBL] [Abstract][Full Text] [Related]
36. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.
Hovnanian A
Cell Tissue Res; 2013 Feb; 351(2):289-300. PubMed ID: 23344365
[TBL] [Abstract][Full Text] [Related]
37. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
Mägert HJ; Kreutzmann P; Drögemüller K; Ständker L; Adermann K; Walden M; John H; Korting HC; Forssmann WG
Eur J Med Res; 2002 Feb; 7(2):49-56. PubMed ID: 11891144
[TBL] [Abstract][Full Text] [Related]
38. Netherton Syndrome Caused by Heterozygous Frameshift Mutation Combined with Homozygous c.1258A>G Polymorphism in
Moltrasio C; Romagnuolo M; Riva D; Colavito D; Ferrucci SM; Marzano AV; Tadini G; Brena M
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239440
[TBL] [Abstract][Full Text] [Related]
39. Characterization and expression analysis of the Spink5 gene, the mouse ortholog of the defective gene in Netherton syndrome.
Galliano MF; Roccasecca RM; Descargues P; Micheloni A; Levy E; Zambruno G; D'Alessio M; Hovnanian A
Genomics; 2005 Apr; 85(4):483-92. PubMed ID: 15780751
[TBL] [Abstract][Full Text] [Related]
40. Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and Finnish SPINK5 Founder Mutation.
Hannula-Jouppi K; Laasanen SL; Ilander M; Furio L; Tuomiranta M; Marttila R; Jeskanen L; Häyry V; Kanerva M; Kivirikko S; Tuomi ML; Heikkilä H; Mustjoki S; Hovnanian A; Ranki A
JAMA Dermatol; 2016 Apr; 152(4):435-42. PubMed ID: 26865388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
